Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1878 (LINC01878)

Target: LINC01878
Molecular classification: Long non-coding RNA, Intergenic lincRNA

Overview

LINC01878, or long intergenic non-protein coding RNA 1878, is a human long intergenic non-coding RNA gene. LincRNAs are non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding loci, are typically transcribed by RNA polymerase II, and play roles in regulating gene expression at various levels, often with tissue- or context-specific patterns[3][5]. While LINC01878 itself is not functionally characterized in detail, lincRNAs as a class can influence chromatin state, transcription, RNA stability, and neighboring gene regulation. In data-driven cancer transcriptomics (e.g., lung cancer studies), LINC01878 has appeared as a feature in multi-gene panels for sample classification, but its explicit biological function or clinical role remains unverified[2].

Other names: LINC01878long intergenic non-protein coding RNA 1878

Mechanism of action

None known. As there are no established drug interactions, no mechanisms of action have been described.

Biological functions

Regulation of gene expression (inferred for lincRNAs by molecular family; explicit functions for LINC01878 specifically are not established in the provided sources)Possible involvement in cancer transcriptomic signatures or cell-type/tumor classification (potential function as a biomarker, but without functional characterization)

Disease associations

Cancer (implicated in cancer-related transcriptomic studies, including lung cancer data mining projects; no direct causal or mechanistic disease association established for LINC01878 itself)

Biomarkers

LINC01878 may serve as a putative transcript marker for cancer classification in bioinformatics models (e.g., for distinguishing lung adenocarcinoma from squamous cell carcinoma), but not yet validated as a clinical biomarker

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1878 (LINC01878).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1878 (LINC01878).

Explore the full profile